The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo
Jingui Ma, Xianliang Xin, Linghua Meng et al. · 2008
Read The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo by Jingui Ma, Xianliang Xin, Linghua Meng et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003774.txt.
Description
Jingui Ma, Xianliang Xin, Linghua Meng, and colleagues published this cancer drug study in PLOS ONE in 2008. Drugs that block several tyrosine kinases at once have shown promise against tumors. Side effects and resistance remain concerns. The team tested a marine-derived compound, an oligosaccharide sulfate called MdOS.
MdOS blocked multiple tyrosine kinases and fought tumor angiogenesis, the growth of new blood vessels that feed tumors. It worked both in cell tests and in living animals. The compound joins the hunt for multi-target cancer drugs with fewer side effects and less resistance.
Catalog record
| CREATOR | Jingui Ma, Xianliang Xin, Linghua Meng et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003774